Rare diseases
Investigational molecules
Locations
Back to Czechia1 231 clinical trials in Prague, Czechia across 17 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in CzechiaKlinickeTesty.cz(opens in a new tab)CzechiaStudy on the Long-Term Safety of PTC923 (Sepiapterin) for Patients with Phenylketonuria
CzechiaStudy on the Safety and Tolerability of Epcoritamab with Drug Combination for Patients with B-cell Non-Hodgkin Lymphoma
CzechiaStudy Comparing MK-2870 with Chemotherapy (Docetaxel or Pemetrexed) for Patients with Advanced Non-Small Cell Lung Cancer with EGFR Mutations
CzechiaCzechiaStudy of Venetoclax and Azacitidine for Maintenance Therapy in Patients with Acute Myeloid Leukemia in First Remission After Chemotherapy
CzechiaStudy on the Safety and Tolerability of Abelacimab Compared to Rivaroxaban in Patients with Atrial Fibrillation
CzechiaStudy on Atezolizumab for Patients with High-Risk Muscle-Invasive Bladder Cancer with Positive ctDNA After Surgery
CzechiaStudy of Nivolumab and Relatlimab for Patients with Stage III-IV Melanoma After Surgery
CzechiaStudy Comparing Radium-223 Dichloride with Abiraterone Acetate, Enzalutamide, and Prednisone in Patients with Advanced Prostate Cancer Spread to the Bone
CzechiaStudy on the Effectiveness and Safety of Cyclophosphamide Monohydrate and Drug Combination for Patients with Persistent or Recurrent Rare Epithelial Ovarian Tumors
CzechiaStudy on the Effectiveness and Safety of Remibrutinib Compared to Placebo and Omalizumab in Adults with Chronic Spontaneous Urticaria Uncontrolled by Antihistamines
CzechiaThe busiest research cities in the country
What the registry says about research in the country
Clinical trial activity in Praha includes research in advanced melanoma and diffuse large B-cell lymphoma, with a strong focus on improving cancer control and extending survival.
These studies are designed to refine how immunotherapy and other cancer treatments perform in everyday clinical care.
Research in cardiovascular diseases is centered on reducing major heart and vascular events, with trials looking at hypertension, atherosclerotic cardiovascular disease, and heart failure prevention.
Several studies aim to improve treatment effectiveness for patients at elevated cardiovascular risk.
Trials in the respiratory field focus on better symptom control and fewer flare-ups in chronic obstructive pulmonary disease, alongside ongoing work in infection-related lung illness.
These studies support more effective care for both chronic and acute respiratory conditions.
Dermatology research in Czechia includes several inflammatory skin disorders, with studies targeting itch, lesion control, and long-term disease management.
The goal is to evaluate new therapies that may ease symptoms and improve quality of life.
Studies in immune-mediated disease are exploring treatments that can calm abnormal inflammation while maintaining safety and tolerability.
These trials aim to improve control of chronic immune-driven disease burden.
Neurology-related research focuses on agitation in Alzheimer's disease dementia, with efforts to better manage behavioral symptoms that affect patients and caregivers.
These studies may help support more practical care for people living with dementia.
Metabolic research in Praha includes trials for overweight, obesity, and related conditions, often linked with cardiovascular risk.
These studies are testing approaches that may help reduce long-term health risks tied to excess weight.
In the area of virus diseases, research is centered on improving treatment options for people with COVID-19 who are at higher risk of becoming seriously ill.
The main aim is to help prevent worsening disease and support faster recovery.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
